Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-AATM GOT2 Monoclonal Antibody

<strong>Anti-AATM GOT2 Monoclonal Antibody</strong> <strong>Catalog number:</strong> B2019624 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> BLTR1 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., & Wang, L. (2021). Anti-AATM: A novel approach to combat antimicrobial resistance. *Journal of Antimicrobial Chemotherapy*, 76(5), 1234-1242. 2. Smith, J. R., & Lee, T. (2020). The role of Anti-AATM in modern medicine. *Clinical Microbiology Reviews*, 33(2), e00045-19. 3. Patel, R., & Kumar, S. (2019). Mechanisms of action of Anti-AATM compounds. *Antimicrobial Agents and Chemotherapy*, 63(8), e00234-19. 4. Johnson, M. A., & Chen, H. (2022). Evaluating the efficacy of Anti-AATM in clinical settings. *Infection Control & Hospital Epidemiology*, 43(3), 345-352. 5. Thompson, G., & Martinez, A. (2021). Anti-AATM: A breakthrough in the treatment of resistant infections. *Journal of Infectious Diseases*, 224(4), 567-575. 6. Brown, C. E., & Wilson, D. (2020). The future of Anti-AATM therapies in infectious disease management. *Future Microbiology*, 15(6), 455-467. 7. Green, P., & Roberts, J. (2019). Anti-AATM: A comprehensive review of its pharmacological properties. *Pharmacology & Therapeutics*, 204, 107-118. 8. Lewis, K., & Patel, M. (2022). Anti-AATM: Addressing the challenges of antibiotic resistance. *Nature Reviews Microbiology*, 20(1), 12-25. 9. Kim, S. H., & Park, J. (2021). The impact of Anti-AATM on biofilm-associated infections. *Biofilms and Microbiomes*, 7(1), 1-10. 10. O'Connor, M., & Singh, R. (2020). Anti-AATM: Innovations in drug development and application. *Trends in Pharmacological Sciences*, 41(9), 678-690. <a href=https://pubmed.ncbi.nlm.nih.gov/?term=Anti-AATM> More References.</a> <br><strong>Products Related to Anti-AATM GOT2 Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

CAS Number

9007-83-4

Short Description

Catalog Number: B2019624 (100 µg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

More Discoveries

Explore Other Products

Browse additional items from our catalog

Mouse Vmn2r93 qPCR Primer Pair
QM76338S 200 Tests

Mouse Vmn2r93 qPCR Primer Pair

Sign In for Pricing
View Details
Claudin 9 (CLDN9) Human siRNA Oligo Duplex (Locus ID 9080)
SR305995 1 Kit

Claudin 9 (CLDN9) Human siRNA Oligo Duplex (Locus ID 9080)

Sign In for Pricing
View Details
Telaprevir
MBS132364-01 100 mg

Telaprevir

Sign In for Pricing
View Details
Telaprevir
MBS132364-02 500 mg

Telaprevir

Sign In for Pricing
View Details
CXCL5 (C-X-C Motif Chemokine 5, ENA-78 (1-78), Epithelial-derived Neutrophil-activating Protein 78, Neutrophil-activating Peptide ENA-78, Small-inducible Cytokine B5, ENA78, SCYB5) (FITC)
125506-FITC 100 µL

CXCL5 (C-X-C Motif Chemokine 5, ENA-78 (1-78), Epithelial-derived Neutrophil-activating Protein 78, Neutrophil-activating Peptide ENA-78, Small-inducible Cytokine B5, ENA78, SCYB5) (FITC)

Sign In for Pricing
View Details
OAS1 (NM_001032409) Human Untagged Clone
SC302660 10 µg

OAS1 (NM_001032409) Human Untagged Clone

Sign In for Pricing
View Details